Abstract
The present invention relates to novel arginase inhibitors of formula (I). These novel compounds are useful in the treatment of diseases that are associated with arginase activity, such as asthma, allergic rhinitis and COPD (chronic obstructive pulmonary disease).
| Original language | English |
|---|---|
| Patent number | WO2020249821 |
| Priority date | 14/06/2019 |
| Filing date | 15/06/2020 |
| Publication status | Published - 12-Dec-2020 |